Skip to main content
. Author manuscript; available in PMC: 2018 Apr 23.
Published in final edited form as: Gene Expr. 2017 Aug 3;17(4):301–312. doi: 10.3727/105221617X15016197658871

Table 4.

Patient Time Frames and Relative M65 and M30/M65 Values

Post Admission Acquisition Time (Days) Days til Mortality from Hospital Admission M65 at Acquisition (U/L) M30/M65 at Acquisition (Ratio) Cause of Death
Pt 1 4 25 15125 0.29 Cardiac/ALF
Pt 45 10 17 31000 0.27 ESLD
Pt 47 2 10 11580 0.18 ESLD
Pt 55 4 13 22050 0.24 Cardiac/ALF
Pt 56 3 17 29019 0.23 Unknown

Representative patient time frames demonstrating sample acquisition time and mortality dates from hospital admission in addition to M65 and M30/M65 ratio. ALF –Acute Liver Failure; ESLD – End-Stage Liver Failure; Pt – Patient.